A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis
NCT07276581
This study is recruiting at 22 US sites in 13 states, according to its ClinicalTrials.gov record last updated .
Summary
Phase II study in participants with moderately-to-severely active rheumatoid Arthritis (RA) to evaluate efficacy and safety of AZD1163.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Rheumatoid Arthritis
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 2
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- AstraZeneca
- Last updated on ClinicalTrials.gov
- October 9, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Arizona · 2
- Research Site · Glendale, AZ
- Research Site · Tucson, AZ
California · 2
- Research Site · La Jolla, CA
- Research Site · San Leandro, CA
Colorado · 1
- Research Site · Aurora, CO
Florida · 1
- Research Site · Winter Haven, FL
Georgia · 1
- Research Site · Marietta, GA
Illinois · 2
- Research Site · Skokie, IL
- Research Site · Willowbrook, IL
Louisiana · 1
- Research Site · Lake Charles, LA
Maryland · 1
- Research Site · Baltimore, MD
Massachusetts · 1
- Research Site · New Bedford, MA
Missouri · 2
- Research Site · Kansas City, MO
- Research Site · St Louis, MO
Nevada · 1
- Research Site · Henderson, NV
South Carolina · 1
- Research Site · Myrtle Beach, SC
Texas · 6
- Research Site · Austin, TX
- Research Site · Baytown, TX
- Research Site · Houston, TX
- Research Site · Houston, TX
- Research Site · Mesquite, TX
- Research Site · Tomball, TX
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.